CLINICAL_TRIALS
ClinicalTrials.gov record update
A Multi-centre, Prospective, Observational Study on Effectiveness and Safety of ZOLADEX® (Goserelin Acetate Implant) 10.8 mg and ZOLADEX® (Goserelin Acetate Implant) 3.6 mg in Chinese Patients With Localized or Locally Advanced Hormonal Treatment -naïve Prostate Cancer
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT03193060
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:39:04.319073+00:00
- Published At
- 2023-07-14T00:00:00+00:00
- Record Updated At
- 2023-07-14
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Localized or Locally Advanced Prostate Cancer"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-07-14"- protocolSection.identificationModule.nctId
"NCT03193060"- protocolSection.identificationModule.officialTitle
"A Multi-centre, Prospective, Observational Study on Effectiveness and Safety of ZOLADEX\u00ae (Goserelin Acetate Implant) 10.8 mg and ZOLADEX\u00ae (Goserelin Acetate Implant) 3.6 mg in Chinese Patients With Localized or Locally Advanced Hormonal Treatment -na\u00efve Prostate Cancer"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
[]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.